NUTRIBAND INC. (NTRB) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-31..
Quick ratio
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-07-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 907.05K USD | Liabilities, Current |
| Cash and equivalents | 3.42M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 23.59K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 170.73K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | (m) | $907.05K | $3.42M | (m) | $23.59K | $170.73K | (m) |
| 2026-04-30 | (m) | $832.14K | $4.01M | (m) | $2.63K | $121.49K | (m) |
| 2026-01-31 | (m) | $784.28K | $4.57M | (m) | $118.40K | $117.99K | (m) |
| 2025-10-31 | (m) | $772.52K | $5.31M | (m) | $147.56K | $136.00K | (m) |
| 2025-07-31 | (m) | $1.57M | $7.00M | (m) | $160.80K | $138.03K | (m) |
| 2025-04-30 | (m) | $925.05K | $2.96M | (m) | $94.14K | $215.32K | (m) |
| 2025-01-31 | (m) | $982.85K | $4.31M | (m) | $73.85K | $212.04K | (m) |
| 2024-10-31 | (m) | $1.25M | $5.70M | (m) | $109.63K | $168.30K | (m) |
| 2024-07-31 | (m) | $1.10M | $6.76M | (m) | $68.01K | $223.86K | (m) |
| 2024-04-30 | (m) | $1.42M | $8.35M | (m) | $85.14K | $168.50K | (m) |
| 2024-01-31 | (m) | $999.09K | $492.94K | (m) | $148.65K | $168.60K | (m) |
| 2023-10-31 | (m) | $717.77K | $1.27M | (m) | $169.67K | $174.64K | (m) |
| 2023-07-31 | (m) | $874.13K | $2.33M | (m) | $223.45K | $156.92K | (m) |
| 2023-04-30 | (m) | $784.39K | $1.28M | (m) | $164.64K | $181.50K | (m) |
| 2023-01-31 | (m) | $748.61K | $1.99M | (m) | $113.05K | $229.34K | (m) |
| 2022-10-31 | (m) | $789.75K | $2.82M | (m) | $80.45K | $184.32K | (m) |
| 2022-07-31 | (m) | $803.92K | $3.34M | (m) | $146.56K | $161.83K | (m) |
| 2022-04-30 | (m) | $723.06K | $4.01M | (m) | $99.10K | $127.53K | (m) |
| 2022-01-31 | (m) | $779.26K | $4.89M | (m) | $71.38K | $131.65K | (m) |
| 2021-10-31 | (m) | $1.00M | $5.49M | (m) | $146.41K | $124.94K | (m) |
| 2021-07-31 | (m) | $2.66M | $304.26K | (m) | $13.77K | $72.60K | (m) |
| 2021-04-30 | (m) | $2.52M | $410.75K | (m) | $150.81K | $90.27K | (m) |
| 2021-01-31 | (m) | $2.57M | $151.99K | (m) | $109.35K | $52.85K | (m) |
| 2020-10-31 | (m) | $2.55M | $193.39K | (m) | $90.66K | $39.21K | (m) |
| 2020-07-31 | (m) | $867.76K | $39.25K | (m) | $14.64K | (m) | (m) |
| 2020-04-30 | (m) | $725.90K | $20.64K | (m) | $39.64K | (m) | (m) |
| 2020-01-31 | (m) | $2.02M | $10.18K | (m) | $12.83K | (m) | (m) |
| 2019-10-31 | (m) | $1.37M | $97.47K | (m) | $71.99K | (m) | (m) |
| 2019-07-31 | (m) | $720.01K | $13.83K | (m) | $70.54K | (m) | (m) |
| 2019-04-30 | (m) | $435.43K | $201.85K | (m) | $44.86K | (m) | (m) |
| 2019-01-31 | (m) | $403.01K | $474.65K | (m) | $13.09K | (m) | (m) |
| 2018-10-31 | (m) | $201.09K | $257.55K | (m) | $94.19K | $4.13K | (m) |
| 2018-07-31 | (m) | $162.12K | $1.10M | (m) | (m) | $54.61K | (m) |
| 2018-04-30 | (m) | $159.83K | (m) | (m) | (m) | $4.13K | (m) |
| 2018-01-31 | (m) | $43.39K | (m) | (m) | (m) | $4.13K | (m) |
| 2017-10-31 | (m) | $34.71K | $102.00 | (m) | (m) | $2.64K | (m) |
| 2017-07-31 | (m) | $17.91K | $7.80K | (m) | (m) | $3.70K | (m) |
| 2017-04-30 | (m) | $22.27K | $593.00 | (m) | (m) | $7.26K | (m) |
| 2017-01-31 | (m) | $14.62K | $27.12K | (m) | (m) | $8.05K | (m) |
| 2016-10-31 | (m) | $46.33K | $857.00 | (m) | (m) | $16.01K | (m) |
| 2016-07-31 | (m) | $33.70K | $6.23K | (m) | (m) | $27.99K | (m) |
| 2016-04-30 | (m) | (m) | $44.57K | (m) | (m) | (m) | (m) |
| 2016-01-31 | (m) | $11.11K | $100.00 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |